SNCA and Parkinson disease: Moreover, the well-established epigenetic induction of SNCA transcription in PD (Jowaed et al., 2010; Matsumoto et al., 2010; Yang et al., 2017) was also recapitulated here (Supplementary Figure S5) and may likewise be classified as adverse and disease-promoting.